Last updated on October 2017

REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)


Brief description of study

HPV-301 is a prospective, randomized, double-blind, placebo controlled Phase 3 study to determine the efficacy, safety, and tolerability of VGX-3100 administered by intramuscular (IM) injection followed by electroporation (EP) delivered with CELLECTRA™ 5PSP in adult women with histologically confirmed cervical high grade squamous intraepithelial lesion (HSIL) (cervical intraepithelial neoplasia grade 2 [CIN2] or grade 3 [CIN3]) associated with human papillomavirus (HPV) 16 and/or HPV-18.

Clinical Study Identifier: NCT03185013

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Danilo Herrera

Coastal Clinical Research Inc
Mobile, AL United States
  Connect »

Ernesto Gomez

Mesa Obstetricians and Gynecologist
Mesa, AZ United States
  Connect »

Micah Harris

Women's Health Research
Phoenix, AZ United States
  Connect »

Cynthia Goldberg

Visions Clinical Research-Tucson
Tucson, AZ United States
  Connect »

Edward Zbella

Women's Medical Research Group, LLC
Clearwater, FL United States
  Connect »

Samuel Lederman

Altus Research
Lake Worth, FL United States
  Connect »

Jacob Tangir

Salom and Tangir LLC
Lake Worth, FL United States
  Connect »

Ronald Ackerman

Comprehensive Clinical Trials LLC
West Palm Beach, FL United States
  Connect »

Daron Ferris

Augusta University
Augusta, GA United States
  Connect »

Stephen Blank

WR-Mount Vernon Clinical Research
Sandy Springs, GA United States
  Connect »

Christine Sanders

Hutchinson Clinic
Hutchinson, KS United States
  Connect »

Kevin Ault

University of Kansas Medical Center
Kansas City, KS United States
  Connect »

Clifton Nicholson-Uhl

Praetorian Pharmaceutical Research, LLC
Marrero, LA United States
  Connect »

Robert Jeanfreau

MedPharmics
Metairie, LA United States
  Connect »

Roger Beyer

Beyer Research
Kalamazoo, MI United States
  Connect »

Thomas Minnec

Saginaw Valley Medical Research Group LLC
Saginaw, MI United States
  Connect »

Mark Garnaas

Montana Medical Research
Missoula, MT United States
  Connect »

Keith Vrbicky

Meridian Clinical Research Norfolk
Norfolk, NE United States
  Connect »

Mark Einstein

New Jersey Medical School
Newark, NJ United States
  Connect »

Ana Tergas

Columbia University Medical Center
New York, NY United States
  Connect »

Kenneth Levey

New York Pelvic Pain and Minimally Invasive Gynecologic Surgery PC
New York, NY United States
  Connect »

Lance Edwards

Suffolk Obstetrics and Gynecology
Port Jefferson, NY United States
  Connect »

Andrea Lukes

Carolina Women's Research and Wellness Center
Durham, NC United States
  Connect »

Robert Parker

Lyndhurst Clinical Research
Winston-Salem, NC United States
  Connect »

Katherine Smith

The University of Oklahoma Health Sciences Center
Oklahoma City, OK United States
  Connect »

David Godwin

Greenville Pharmaceutical Research, Inc.
Greenville, SC United States
  Connect »

Helena Kirkpatrick

Magnolia Ob/Gyn Research Center, LLC
Myrtle Beach, SC United States
  Connect »

Kirk Brody

Chattanooga Medical Research Inc
Chattanooga, TN United States
  Connect »

Belvia Carter

Women's Physician Group
Memphis, TN United States
  Connect »

Sandra Hurtado

The Woman's Hospital of Texas
Houston, TX United States
  Connect »

Kourtney Sims

BI Research Center
Houston, TX United States
  Connect »

Kevin O'Neil

MacArthur Obstetrics and Gynecology
Irving, TX United States
  Connect »

Mohamad Parva

Group For Women
Norfolk, VA United States
  Connect »

Thomas Kimble

Eastern Virginia Medical School
Norfolk, VA United States
  Connect »

James Rice

Multicare Health System
Covington, WA United States
  Connect »

Ronald Hardy

North Spokane Women's Clinic
Spokane, WA United States
  Connect »

Josefina Romaguera

Puerto Rico Translational Research Center (PRTRC)
Rio Piedras, Puerto Rico
  Connect »